Rhodococcus equi is an unusual cause of infection in humans. Infection in immunocompetent patients is extremely rare-only 19 cases in immunocompetent hosts have been reported. Localized infections represent nearly 50% of reported cases. Pulmonary infections account for only 42% of infections in immunocompetent hosts, compared with 84% of infections in immunocompromised hosts. The mortality rate among immunocompetent patients is ∼11%, compared with rates of 50%-55% among human immunodeficiency virus (HIV)-infected patients and 20%-25% among non-HIV-infected immunocompromised patients. Treatment of infections in immunocompetent hosts depends on the site of infection. Serious infections need to be treated with combinations of parenteral antibiotics, followed by combinations of oral antibiotics. Surgical treatment is necessary for certain types of local infections. We report a pulmonary infection due to R. equi in an immunocompetent patient, and we review all reported cases of R. equi infection in immunocompetent hosts.
The results of neurological examination were normal. A chest radiograph and CT of the thorax, done at the time of admission to the hospital, demonstrated multiple nodular infiltrates in both lung fields (figure 1A, 1B). There was no mediastinal or hilar lymphadenopathy. Laboratory studies disclosed the following values: peripheral leukocytes, cells/L; neutro- 9 16.6 ϫ 10 phil count, cells/L; hemoglobin, 117 g/L; erythrocyte 9 12.6 ϫ 10 sedimentation rate, 136 mm/h; serum albumin, 29 g/L; total bilirubin, 0.05 g/L; g-glutamyl transferase, 289 U/L; aspartate aminotransferase, 97 U/L; alanine aminotransferase, 94 U/L; and international normalized ratio, 1.07.
Examination of sputum samples for acid-fast bacilli (AFB) on 3 consecutive days yielded negative results. The results of bronchoscopy with bronchial brushings and washings were negative for AFB, viral and fungal growth, and malignant cells. A transesophageal echocardiogram incidentally showed cardiomyopathy with an ejection fraction of 20%-30% and no evidence of vegetation. Results of an HIV screening test were negative, and the patient's CD4 ϩ T lymphocyte count was 1080 cells/mm 3 . A serological screening test for hepatitis C yielded positive results. There was no evidence of cirrhosis or portal hypertension on abdominal ultrasound (done at a later date). Urinalysis did not show RBC casts. The results of tests for cytoplasmic antineutrophil cytoplasmic antibody and perinuclear antineutrophil cytoplasmic antibody in serum samples were negative. Serial chest radiographs showed that the nodules had progressed to cavitary lesions and, subsequently, to abscesses ( figure 1C ). Culture of a CT-guided aspirate yielded group F streptococci and Bacteroides uniformis. The patient received empirical treatment with ceftriaxone, metronidazole, and penicillin G. There was no significant response to the antibiotics. One of the cultures for fungi done on blood samples during the initial hospitalization yielded an organism that was later identified as R. equi. He was then treated with iv vancomycin, ceftriaxone, oral rifampin, and metronidazole, to which he showed a dramatic clinical and radiological response.
On 26 June, the patient was discharged from the hospital while receiving the aforementioned antibiotic regimen. After 8 weeks, the antibiotic regimen was changed to oral rifampin and erythromycin for 12 additional weeks. He completed treatment in November 1998. The patient has since been doing well and does not have any evidence of recurrence on CT (figure 1D, 1E). Antibiotic susceptibility testing done later showed that the organism (R. equi) was susceptible to erythromycin, azithromycin, and rifampin, and that it was resistant to trimethoprimsulfamethoxazole (TMP-SMX) and clindamycin. Susceptibilities to vancomycin and ceftriaxone were not tested.
During a subsequent interview with the patient, it was learned that, 3 weeks before admission, he had been stranded for several hours in a horse stable. It had been a windy day, and the patient had been waiting for a ride home after his car had broken down. There was no history of alteration in mental status, alcohol ingestion, or seizures at that time.
RESULTS AND DISCUSSION
R. equi, previously called "Corynebacterium equi," primarily causes zoonotic infection and mainly affects grazing animals [2] . It is a facultative, intracellular, nonmotile, non-sporeforming, gram-positive organism that has the ability to change between coccus and rod forms (therefore, it was given the name "coccobacillus") [2, 3] . It is called Rhodococcus because of its ability to form a red (salmon-colored) pigment [1, 2] . It can be weakly acid fast [3] . Its ability to persist in macrophages forms the core of its pathogenesis [2] . The most common form of infection is necrotizing pneumonia, which may be complicated by abscesses, empyema, pleural effusion, and spontaneous pneumothorax [4] . Extrapulmonary infection may include wound infections, subcutaneous abscesses, brain abscesses, meningitis, pericarditis, osteomyelitis, cervical adenopathy, endophthalmitis, lymphangitis, or mastoiditis.
R. equi is a rare cause of infection in immunocompetent hosts (tables 1 and 2). Only 19 cases reported in this population have been proven unequivocally to be caused by R. equi. Infection in immunocompetent patients has a wide range, varying from localized infection secondary to trauma, to fatal systemic infection. Systemic infections include 8 reports of pulmonary infection and 1 report of fever of unknown origin. Endophthalmitis, traumatic meningitis, lymphadenitis, lymphangitis, septic arthritis, and osteitis represent the remainder of the infections.
Demographics. Among cases of R. equi infection that have been reported in immunocompetent hosts, the male-to-female ratio of patients is 3:1, which is the same as that reported in immunocompromised hosts. The reason for this finding in immunocompetent patients is not clear; however, in immunocompromised patients, it can be explained in part by the higher prevalence of HIV infection in male patients. Localized infections represented a significant portion (47%) of the infections in immunocompetent patients, perhaps because of the ability of immunocompetent patients to contain the infection. Two-thirds of the localized infections occurred in children, and all infections in children were localized. Infections in children accounted for 31% of cases. This may be because of an increased occurrence of trauma in children, which may predispose them to localized wound infections with R. equi. Pulmonary involvement accounted for only ∼42% of infections in immunocompetent hosts, compared with 84% of infections in immunocompromised hosts, as reported by Verville et al. [2] .
Epidemiology. R. equi has been found in bovine, porcine, and equine fecal flora. It grows best at a summer temperature (variable [∼18ЊC-29ЊC]). On horse farms, isolation of the or- ganism from the air increases as ambient temperature increases and is highest on dry, windy days [17] . Infection is primarily acquired through the respiratory tract but has been found to be acquired both by the oral route [5] and by traumatic inoculation or superinfection of wounds [2, 6, 7, 14] . Epidemiological features, such as history of exposure to livestock or contamination with soil, that may have led to R. equi infection were found in 10 of 19 patients (table 1) . However, in a case of endophthalmitis reported by Ebersole and Paturzo [6] , the trauma occurred ∼1 month before the onset of endophthalmitis. This delay makes it an unlikely source of infection. In 2 other cases, exposure to dogs was mentioned as a possible source of infection [2, 15] . However, R. equi is a pathogen primarily in grazing animals, although it has been isolated as a colonizer or, rarely, as a cause of infection in dogs [17] . Infection acquired by oral inoculation has also been described NOTE. Amik, amikacin; Amp, ampicillin; Amp-Sulb, ampicillin-sulbactam; Azm, azithromycin; Cfaz, cefazolin; Chl, chloramphenicol; Clex, cephalexin; Cm, clindamycin; Cpfx, ciprofloxacin; Csul, cefsulodin; Ctax, cefotaxime; Cthn, cephalothin; Ctri, ceftriaxone; Czid, ceftazidime; Em, erythromycin; Fcd, fucidin; Gm, gentamicin; Lmx, latamoxef; Mino, minocycline; Mtz, metronidazole; Naf, nafcillin; Net, netilmicin; Nm, neomycin; Ofx, ofloxacin; Odz, ornidazole; Pip, piperacillin; Rif, rifampin; Stm, streptomycin; Stz, sulphathiazole; Tet, tetracycline; Tic, ticarcillin; TMP-SMX, trimethoprim-sulfamethoxazole; Tnz, tinidazole; Vm, vancomycin.
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[5]. This infection was suspected in a child found to be sucking raw carrots from a neighboring farm. The authors were able to isolate the organism from soil samples obtained from the neighboring farm. Clinical features. The presenting symptoms of R. equi infection depend on the site of infection. Symptoms of pulmonary infection include dyspnea, cough (which may be nonproductive), pleuritic chest pain, and fever. Other presenting symptoms include such features as lymphadenopathy, eye drainage and eye pain, altered level of consciousness, and joint pain. In localized infections secondary to trauma, such as endophthalmitis, septic arthritis, and meningitis, symptoms occurred within 24 h of the trauma [2, 7, 14] . The onset of symptoms in pulmonary infections is insidious and, in our patient, occurred 1 week after exposure to horses. Two patients with pulmonary infections had a rather chronic course of infection. They presented with recurrent pneumonia that did not respond to empirical antibiotic therapy. One of them was treated with minocycline and piperacillin for 1 month [9] , and the other was treated with macrolides only for an unknown duration [15] . Therefore, it is important to recognize R. equi as a possible etiologic agent when an immunocompetent patient presents with recurrent pneumonia.
The radiological findings for immunocompetent patients with pulmonary infections are summarized in table 1. Although there are some reports of preference for infection of the upper lobes of HIV-infected individuals [4, 18] , we found no such predilection for infection of any particular lobe. A review of the radiological findings in pulmonary infections in immunocompetent hosts showed involvement of the upper lobes in 50%, the middle lobes in 50%, and the lower lobes in 62%. Sixty-two percent of patients with pulmonary infection had cavitation, 5% demonstrated pleural effusion, and 5% had bronchobiliary fistula. The rates of pulmonary complications in other reports are 54%-69% cavitation in all subgroups of patients, in contrast to 67%-77% cavitation in HIV-infected persons [2] [3] [4] 19] . Effusions or empyemas have been reported in 18%-34% [2, 3] and hemoptysis in 20% [3] of all subgroups of patients with pulmonary infection. The cavities seen with R. equi infections tend to have thick walls and may contain airfluid levels that indicate formation of an abscess [17] . CT of the chest may reveal cavitary lesions not seen on chest radiography. The radiograph of the single case of mandibular osteitis showed an irregular osteolytic lesion of the mandible [12] . CT and MRI showed a soft-tissue mass with a necrotic center that eroded the bone.
Diagnosis. Specimens obtained for diagnosis of local infections by culture were biopsy specimens and aspirates from the site of infection. Biopsy of bone marrow was required for diagnosis in a patient who presented with fever of unknown origin [16] . Blood was the source of isolation of R. equi in a case of cervical lymphadenopathy in a 3-year-old child [2] . This emphasizes the importance of also obtaining blood samples for culture in cases of localized infection. Overall, blood samples for culture were obtained from only 8 patients, and culture yielded positive results for 30% of them. This compares with the 83% rate of positive blood culture results found among 12 cases of R. equi infection in HIV-infected patients described by Donisi et al. [20] . Harvey and Sunstrum [19] reported 100% positive results of blood cultures for HIV-infected patients with pulmonary infection.
For the 8 cases of pulmonary infection shown in tables 1 and 2, the diagnosis was obtained from sputum samples in 3 patients, blood culture in 2, bronchial washings in 1, and biopsy specimens obtained during thoracotomy in 2. Bronchoscopy with washings and bronchoalveolar lavage were done for 4 patients with pulmonary infection and yielded positive results for only 1 patient. Harvey and Sunstrom [19] reported that bronchial washings or bronchoalveolar lavage was positive in 66% of HIV-infected patients with pulmonary infection, although it is not known how many patients had bronchoscopy for diagnosis. Pulmonary malacoplakia is a histopathological finding reported to occur among HIV-infected patients with R. equi pulmonary infections diagnosed by biopsy and fine-needle aspiration [21, 22] . This finding has not yet been reported for pulmonary infections in immunocompetent patients; however, if found, it may be a clue to infection with R. equi.
There were 4 other case reports of infections caused by an organism that belonged to the genus Rhodococcus and that resembled R. equi, for which species identification could not be done. Results of biochemical tests showed several differences between this organism and R. equi; therefore, the species could not be ascertained. Spark et al. [23] reported a case of fatal pneumonia and adult respiratory distress syndrome caused by an uncharacterized species of the genus Rhodococcus. The isolate's biochemical reactions and pattern of RNA gene-containing restriction fragments were significantly different from those of the 20 recognized species of Rhodococcus. Muller et al. [24] reported a case of superficial wound infection in a previously healthy 13-year-old boy. The organism showed poor growth at 37ЊC and had biochemical characteristics unusual for R. equi. The authors concluded that the organism was either a poorly growing variant of R. equi or an uncharacterized species of Rhodococcus. Broughten [25] reported, in a 29-monthold infant, septic arthritis and osteomyelitis caused by an organism belonging to the Rhodococcus genus. Martin et al. [26] reported axillary lymphadenitis in a 7-year-old girl who was initially treated with isoniazid and rifampin for presumptive infection with Mycobacterium tuberculosis. The treatment was stopped after 2 months because it was believed that M. tuberculosis was an unlikely cause of her infection. The infection resolved over the next few months. These 4 cases are therefore not included in tables 1 and 2.
Infection with R. equi in immunocompetent hosts is rare. Clues to the infection include exposure to livestock; favorable environmental conditions for growth of the organism, such as dry, windy conditions; insidious onset of pneumonia or recurrent pneumonia [17] ; typical radiological features, such as nodules, cavitations, abscesses, or necrotizing pneumonia; and sputum sample findings of "diphtheroids or nonpathogenic organisms."
Studies of in vitro antibiotic susceptibilities have shown that R. equi is usually susceptible to erythromycin, rifampin, ciprofloxacin, vancomycin, aminoglycosides [1, 2, 18] , imipenem, and meropenem [18] . The organism is usually resistant to penicillin G, oxacillin, ampicillin, carbenicillin, and cefazolin. Susceptibilities to clindamycin, ceftriaxone, TMP-SMX, tetracycline, and chloramphenicol are variable. Some studies also report excellent activity against R. equi with the use of ampicillin-sulbactam and amoxicillin-clavulanate [17] . There generally is widespread resistance to b-lactams, with the exception of imipenem and meropenem. Although in vitro susceptibilities sometimes show susceptibility to b-lactams (as is evident in tables 1 and 2), there are several reports of acquired resistance to b-lactams occurring in previously susceptible isolates during treatment [2, 3, 10] . Some authors recommend the use of at least 1 antibiotic with intracellular penetration, such as erythromycin or rifampin [2, 3, 10, 19] . In vitro synergy studies conducted by Nordmann and Ronco [27] demonstrated 4 combinations of drugs to be effective against R. equi infection: rifampin-erythromycin, rifampin-minocycline, erythromycinminocycline, and imipenem-amikacin [27] . Macrolides and aminoglycosides were found to be antagonistic when used in combination, although they have been used clinically with success. Antagonism between imipenem and certain b-lactams in vitro was also detected [28] . In another study conducted in a model of iv infected nude mice, Nordmann et al. [29] reported that vancomycin, imipenem, and rifampin were the most effective single agents, and the most-effective drug combinations included vancomycin. Combinations of drugs were not more effective than vancomycin alone; however, combinations of antibiotics may act by limiting the emergence of in vivo antibioticresistant mutants rather than by further decreasing the bacterial inoculum [29] .
Treatment of R. equi infections reported in immunocompetent hosts is also summarized in table 2. Selective local infections without evidence of systemic involvement can be treated with shorter courses of antibiotics with or without local surgical therapy. Infections such as lymphadenitis or lymphangitis were treated with either short courses of parenteral antibiotic or a 4-8-week course of oral antibiotics. Local eye infections, such as endophthalmitis, were treated with vitrectomy and 1 week of parenteral antibiotics in combination with topical antibiotics. The single case of septic arthritis was treated with arthrotomy and a parenteral antibiotic during the perioperative period.
There are insufficient data regarding the treatment of pulmonary infections and other serious infections in immunocompetent hosts. Treatment literature is only anecdotal, and our recommendation for treatment is based on a review of the literature on both immunocompromised and immunocompetent patients. Several authors recommend treatment of pulmonary infections for a minimum of 2 months [2, 3, 10, 17] . Treatment should initially consist of parenteral antibiotics, followed by oral combination therapy. Nordmann et al. [29] recommended initial therapy with vancomycin-based combination antibiotics, followed by oral combination therapy with either rifampin-erythromycin or rifampin-minocycline. These guidelines primarily have been based on studies that assess infections in immunocompromised hosts. However, to treat pulmonary infection in immunocompetent hosts, a shorter duration of therapy may be considered, since clinical success has been achieved with shorter courses of therapy (table 2). It seems prudent to continue parenteral therapy until the clinical condition and pulmonary infiltrates stabilize, and to continue oral antibiotics until the infiltrates resolve [10] . Even before diagnosis was established, surgical treatment was used for 2 patients with pulmonary infection. Surgical treatment should be considered for patients with pulmonary infections, when there is chronicity or failure to respond to antibiotic therapy alone or when there is extensive pulmonary involvement.
The patient with mandibular osteitis (patient 13; see tables 1 and 2) experienced a relapse after having received therapy with combination oral antibiotics for 8 months. She refused surgical treatment and received an additional course of combination oral antibiotic therapy. Therefore, for cases of osteitis and osteomyelitis, parenteral antibiotic treatment followed by combination oral antibiotic therapy may be necessary. In addition, surgical treatment should be considered. The single case of meningitis was treated successfully with a combination of parenteral antibiotics for 2 weeks, followed by treatment with a single oral antibiotic for 2 more weeks. A case of fever of unknown origin was treated with erythromycin alone for 4 weeks.
Among the 19 patients, there was only 1 relapse of the infection. This relapse occurred in the woman with mandibular osteitis described above (patient 13) [12] . Four patients either had recurrence or failure to improve after receiving either empirical antibiotic therapy with b-lactams or single-agent macrolide therapy [8, 9, 11, 15] . Therapy with b-lactams other than imipenem and meropenem should be avoided for the aforementioned reasons, despite in vitro susceptibility.
The mortality rate among immunocompetent patients (table  1) was ∼11%, compared with mortality rates of 50%-55% among HIV-infected patients and 20%-25% among non-HIV-infected immunocompromised patients [17, 19] . The 2 deaths that have been reported among the immunocompetent patients were cases of pulmonary infections. One of the deaths was probably at least partially attributable to a complicated past medical history, which included amebic dysentery, hepatic abscess, bronchobiliary fistula, and the subsequent chronic nature of the infection [8] . He was treated empirically with amoxicillin and tinidazole. The other patient was an 83-year-old woman who died even before the organism was identified [11] . She was empirically treated with ampicillin-sulbactam for community-acquired pneumonia.
The significant mortality rate among immunocompetent hosts may be related to inappropriate initial antibiotic therapy, because R. equi is frequently mistaken for a contaminant diphtheroid. R. equi may be easily overgrown in mixed cultures because of its slower growth [17] . Misidentification of R. equi as Mycobacterium species may occur because of its variably acidfast nature and clinical similarity. R. equi also does not respond to standard empirical therapy [30] with b-lactams and tetra-cyclines. Macrolides and the newer quinolones may, however, be effective against R. equi pneumonia.
In our patient, R. equi was obtained from culture of blood samples only and not from sputum samples or CT-guided aspirates. The negative results of cultures of sputum samples and aspirates may have been due to the overgrowth of other organisms (e.g., B. uniformis and group F streptococci) and possible mistaken identification as a contaminant. We strongly suspect that the patient had pulmonary infection due to R. equi. To ensure cure, we treated him for a prolonged duration, although he was immunocompetent. The patient did not have any evidence of cirrhosis or coagulopathy. Therefore, we believe that he was not immunocompromised, although he had chronic hepatitis C.
Infection with R. equi can be fatal, even in immunocompetent hosts. Infections due to this organism are increasing. This may be because of the HIV epidemic and improvements in laboratory techniques for detection. R. equi infection should be included in the differential diagnosis of community-acquired pneumonia in patients who do not respond to empirical therapy with b-lactam antibiotics. However, the quinolone group of antibiotics, which is increasingly used to treat communityacquired pneumonia, may also include effective agents against R. equi. It is important to have a high index of suspicion for the diagnosis of this potentially curable infection, which may otherwise be fatal. Antibiotic therapy should be guided by the susceptibility studies. Treatment depends on the type of infection and may require prolonged duration of antibiotics. Treatment in general should consist of combination antibiotic therapy.
